Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy-Reference-Cited by-同舟云学术

Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy

Published:2013-01-03 Issue:4 Volume:19 Page:938-948
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Mahfouz Reda Z.,Jankowska Ania,Ebrahem Quteba,Gu Xiaorong,Visconte Valeria,Tabarroki Ali,Terse Pramod,Covey Joseph,Chan Kenneth,Ling Yonghua,Engelke Kory J.,Sekeres Mikkael A.,Tiu Ramon,Maciejewski Jaroslaw,Radivoyevitch Tomas,Saunthararajah Yogen

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance;2024-05-21

2. Synthesis of 1,4-azaphosphinine nucleosides and evaluation as inhibitors of human cytidine deaminase and APOBEC3A;Beilstein Journal of Organic Chemistry;2024-05-15

3. Studies on the Thermal Decomposition Course of Nitrogen-Rich Heterocyclic Esters as Potential Drug Candidates and Evaluation of Their Thermal Stability and Properties;International Journal of Molecular Sciences;2024-04-27

4. Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine;Cancer Reports;2023-11-28

5. Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients;Cancer Chemotherapy and Pharmacology;2023-09-05